Małgorzata Milewska
Royal College of Surgeons in Ireland(IE)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics, Advanced Breast Cancer Therapies, MicroRNA in disease regulation
Most-Cited Works
- → Overexpression of the microRNA miR‐433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells(2015)160 cited
- → Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies(2017)34 cited
- → Identification of novel spartin‐interactors shows spartin is a multifunctional protein(2009)29 cited
- → A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib(2017)22 cited
- → Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH)(2018)22 cited
- → The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer(2016)20 cited
- → Mig-6 participates in the regulation of cell senescence and retinoblastoma protein phosphorylation(2014)16 cited
- → Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers(2018)15 cited
- → Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer(2018)13 cited
- → Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation(2015)10 cited